These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

959 related items for PubMed ID: 6240408

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S, Tamura N, Fujita T.
    Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642
    [Abstract] [Full Text] [Related]

  • 3. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF.
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [Abstract] [Full Text] [Related]

  • 4. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
    Gigli I, Sorvillo J, Halbwachs-Mecarelli L.
    J Immunol; 1985 Jul; 135(1):440-4. PubMed ID: 3158705
    [Abstract] [Full Text] [Related]

  • 5. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK.
    J Immunol; 1986 Mar 15; 136(6):2216-21. PubMed ID: 2419425
    [Abstract] [Full Text] [Related]

  • 6. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
    Thielens NM, Colomb MG.
    Eur J Immunol; 1986 Jun 15; 16(6):617-22. PubMed ID: 3487454
    [Abstract] [Full Text] [Related]

  • 7. Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.
    Daha MR, van Es LA.
    J Immunol; 1979 Mar 15; 122(3):801-5. PubMed ID: 448075
    [Abstract] [Full Text] [Related]

  • 8. C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium.
    Fishelson Z, Müller-Eberhard HJ.
    J Immunol; 1982 Dec 15; 129(6):2603-7. PubMed ID: 6923908
    [Abstract] [Full Text] [Related]

  • 9. Complement activation by heat-killed human kidney cells: formation, activity, and stabilization of cell-bound C3 convertases.
    Baker PJ, Adler S, Yang Y, Couser WG.
    J Immunol; 1984 Aug 15; 133(2):877-81. PubMed ID: 6376629
    [Abstract] [Full Text] [Related]

  • 10. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 15; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 11. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T, Takata Y, Kozono H, Takeda J, Hong KS, Inoue K.
    J Immunol; 1988 Dec 01; 141(11):3895-901. PubMed ID: 3183384
    [Abstract] [Full Text] [Related]

  • 12. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
    Sobel AT, Cooper NR, Schreiber RD.
    J Immunol; 1979 Jan 01; 122(1):34-8. PubMed ID: 762421
    [Abstract] [Full Text] [Related]

  • 13. Complement receptor is an inhibitor of the complement cascade.
    Iida K, Nussenzweig V.
    J Exp Med; 1981 May 01; 153(5):1138-50. PubMed ID: 6910481
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
    Gigli I, Sorvillo J, Mecarelli-Halbwachs L, Leibowitch J.
    J Exp Med; 1981 Jul 01; 154(1):1-12. PubMed ID: 7019379
    [Abstract] [Full Text] [Related]

  • 15. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T, Holers VM, Atkinson JP.
    J Immunol; 1985 Oct 01; 135(4):2661-7. PubMed ID: 3161944
    [Abstract] [Full Text] [Related]

  • 16. Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase.
    Rawal N, Pangburn MK.
    Mol Immunol; 2007 Feb 01; 44(6):1105-14. PubMed ID: 16979240
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
    Saint-Remy JM.
    Eur J Immunol; 1984 Mar 01; 14(3):254-9. PubMed ID: 6608450
    [Abstract] [Full Text] [Related]

  • 18. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC, Peters DK.
    Clin Exp Immunol; 1986 Aug 01; 65(2):450-7. PubMed ID: 3641695
    [Abstract] [Full Text] [Related]

  • 19. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M, Balow JE, Tsokos GC.
    J Immunol; 1986 Jun 15; 136(12):4451-5. PubMed ID: 3011894
    [Abstract] [Full Text] [Related]

  • 20. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
    Medof ME, Nussenzweig V.
    J Exp Med; 1984 Jun 01; 159(6):1669-85. PubMed ID: 6233387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.